Doç.Dr. Ozan Balakan

2002-2004 A 9061007 kodlu hafif-orta şiddette hipertansiyonlu hastalarda kinapril yada kinapril artı hidroklorotiazidin etkinliği ve emniyetini değerlendiren 12 haftalık açık kontrolsüz çok merkezli çalışma

2009-2012 Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

2009-2012 AGENNIX FORTIS-M. A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Patients With Non-small Cell Lung Cancer Who Have Failed Two or More Prior Treatment Regimens

2010-2012 Celtrion CTP-6 Meme ca da CTP-6 & Trastuzumab karşılaştırmalı etkinlik çalışması

2010-2012 CURRENT S A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)

2010-2012 BMS CA184-095 CA184-095: A randomized, double-blind, phase III trial to compare the efficacy of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients (pts) with metastatic chemotherapy-naive castration-resistant prostate cancer (CRPC).

2010-2012 LOGİC EGF 110656  A phase III study of ERB2 positive advanced or metastatic gastric, esophageal or gastrophageal junction adenocarcinoma treated with capecitabine plus oxaliplatin with or without lapatinib

2011-2012 Imclone CP12-0715 A Phase 3, Randomized, Double-Blinded Study of IMC-1121B and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy

2011-2012 RO5185426 Metastatik malign melanomada vemurafenib İnsani amaçlı erken erişim programı

2012-2012 LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

2009-2011 ML21440 A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer